News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
72,446 Results
Type
Article (1428)
Company Profile (2)
Press Release (71016)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (18551)
Career Advice (207)
Deals (4473)
Drug Delivery (2)
Drug Development (13565)
Employer Resources (15)
FDA (2720)
Job Trends (2391)
News (40271)
Policy (4674)
Tag
2024 BioCapital Digital (2)
Academia (122)
Accelerated approval (2)
Allergies (10)
Alliances (4412)
ALS (1)
Alzheimer's disease (149)
Antibody-drug conjugate (ADC) (7)
Approvals (2777)
Artificial intelligence (20)
Autoimmune disease (3)
Automation (2)
Bankruptcy (49)
Best Places to Work (2387)
BIOSECURE Act (1)
Biosimilars (17)
Biotechnology (2)
Bladder cancer (35)
Brain cancer (2)
Breast cancer (59)
Cancer (468)
Cardiovascular disease (32)
Career advice (183)
CAR-T (12)
Cell therapy (42)
Cervical cancer (6)
Clinical research (11993)
Collaboration (107)
Compensation (40)
Complete response letters (1)
COVID-19 (252)
C-suite (12)
Cystic fibrosis (22)
Data (527)
Denatured (1)
Depression (6)
Diabetes (48)
Diagnostics (749)
Digital health (3)
Diversity, equity & inclusion (4)
Drug discovery (17)
Drug pricing (2)
Drug shortages (3)
Duchenne muscular dystrophy (17)
Earnings (10660)
Employer branding (1)
Employer resources (13)
Events (9823)
Executive appointments (64)
FDA (3012)
Funding (83)
Gene editing (5)
Gene therapy (30)
GLP-1 (80)
Government (488)
Grass and pollen (1)
Guidances (14)
Healthcare (1952)
IgA nephropathy (3)
Immunology and inflammation (6)
Indications (13)
Infectious disease (272)
Inflammatory bowel disease (23)
Influenza (13)
Intellectual property (19)
Interviews (45)
IPO (2413)
Job creations (160)
Job search strategy (155)
Kidney cancer (1)
Labor market (1)
Layoffs (10)
Leadership (1)
Legal (967)
Liver cancer (11)
Lung cancer (93)
Lymphoma (45)
Management (7)
Manufacturing (27)
MASH (19)
Medical device (1413)
Medtech (1414)
Mergers & acquisitions (2179)
Metabolic disorders (102)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (6)
Neuropsychiatric disorders (4)
Neuroscience (217)
NextGen: Class of 2025 (448)
Non-profit (302)
Northern California (389)
Obesity (35)
Opinion (11)
Ovarian cancer (15)
Pain (8)
Pancreatic cancer (18)
Parkinson's disease (19)
Partnered (1)
Patents (45)
Patient recruitment (16)
Peanut (5)
People (3508)
Pharmaceutical (4)
Phase I (3178)
Phase II (4810)
Phase III (4749)
Pipeline (281)
Policy (5)
Postmarket research (586)
Preclinical (961)
Press Release (12)
Prostate cancer (24)
Psychedelics (1)
Radiopharmaceuticals (35)
Rare diseases (64)
Real estate (271)
Recruiting (3)
Regulatory (3606)
Reports (3)
Research institute (118)
Resumes & cover letters (25)
Rett syndrome (1)
RSV (7)
Schizophrenia (15)
Series A (8)
Series B (6)
Service/supplier (1)
Sickle cell disease (7)
Southern California (475)
Spinal muscular atrophy (11)
Sponsored (2)
Startups (155)
Stomach cancer (2)
Supply chain (7)
United States (3677)
Vaccines (62)
Venture capitalists (1)
Weight loss (15)
Women's health (1)
Date
Today (34)
Last 7 days (129)
Last 30 days (431)
Last 365 days (5432)
2025 (1650)
2024 (5649)
2023 (6155)
2022 (6743)
2021 (7433)
2020 (7004)
2019 (4887)
2018 (3858)
2017 (3840)
2016 (3211)
2015 (3732)
2014 (2596)
2013 (1943)
2012 (2029)
2011 (2117)
2010 (1825)
Location
Africa (88)
Alabama (20)
Arizona (14)
Arkansas (1)
Asia (4400)
Australia (645)
California (1020)
Canada (313)
China (55)
Colorado (39)
Connecticut (45)
Delaware (32)
Europe (9635)
Florida (168)
Georgia (33)
Idaho (6)
Illinois (68)
India (7)
Indiana (34)
Japan (33)
Kansas (27)
Kentucky (1)
Maine (4)
Maryland (127)
Massachusetts (579)
Michigan (53)
Minnesota (28)
Missouri (7)
Nebraska (1)
Nevada (21)
New Hampshire (5)
New Jersey (412)
New Mexico (1)
New York (355)
North Carolina (152)
North Dakota (1)
Northern California (389)
Ohio (11)
Oregon (2)
Pennsylvania (193)
Rhode Island (3)
South America (158)
South Carolina (3)
Southern California (475)
Tennessee (6)
Texas (149)
Utah (29)
Virginia (9)
Washington D.C. (12)
Washington State (89)
West Virginia (1)
72,446 Results for "andor".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tenax Therapeutics Appoints Gillian Andor Vice President, Clinical Operations
January 22, 2025
·
4 min read
Press Releases
Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
April 15, 2025
·
8 min read
Press Releases
Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure
April 1, 2025
·
6 min read
Press Releases
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
March 5, 2025
·
7 min read
Press Releases
Vivex Biologics, Inc. Provides Enrollment Update for its ASCEND Study Examining Whether Supplementing Discs with VIA Disc NP™ Reduces Pain and/or Improves Function in Patients with Symptomatic Disc Degeneration
April 9, 2025
·
2 min read
Press Releases
Yingli Pharma Announces Successful End-of-Phase 2 Meeting with FDA and Clearance of Global Multi-center Phase 3 Registration Study Design of Linperlisib for the Treatment of Relapsed and/or Refractory Peripheral T-cell Lymphoma
April 2, 2025
·
3 min read
Drug Development
Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929 Photoimmunotherapy in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to be Presented at ASCO 2024
Rakuten Medical, Inc. announced the updated safety and efficacy findings from an interim evaluation of an open-label Phase 1b/2 study of photoimmunotherapy using ASP-1929 in combination with anti-PD-1 for recurrent and/or metastatic head and neck squamous cell carcinoma.
May 24, 2024
·
8 min read
Press Releases
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia
December 10, 2024
·
16 min read
Biotech Bay
Soleno Therapeutics Announces Proposed Public Offering of Common Stock and/or Pre-Funded Warrants and a Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced that it intends to offer and sell shares of its common stock and/or pre-funded warrants in an underwritten public offering.
September 27, 2023
·
4 min read
Drug Development
NewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib and Ezetimibe in Patients with HeFH and/or ASCVD
NewAmsterdam Pharma Company N.V. announced the dosing of the first patient and initiation of TANDEM, a pivotal Phase 3 clinical trial to evaluate obicetrapib and ezetimibe FDC in adult patients with Heterozygous Familial Hypercholesterolemia and/or Atherosclerotic Cardiovascular Disease or multiple risk factors for ASCVD, whose LDL-C is not adequately controlled despite being on maximally tolerated lipid-modifying therapies.
March 12, 2024
·
9 min read
1 of 7,245
Next
